久久久久免费_精品国产乱码久久久久久久软件_欧美一区亚洲一区_国产一区二区三区高清在线观看_欧美日在线观看_成人网av

美國分子儀器公司 Molecular Devices     
美國分子儀器公司（MDC）是NASDAQ上市公司，全球高品質生物分析檢測系統(tǒng)的先導者。我們的產品整合了工程學、分子和細胞生物學、電生理學和化學等學科的高新技術，廣泛應用于分子生物學、免疫學、細胞學、生物化學、電生理、高通量藥物篩選和藥物開發(fā)等領域，并且在全球酶標儀市場和藥物篩選領域具有極高的口碑。

公司的全球總部位于美國硅谷，在英國、德國、挪威、韓國和日本均設有分支機構。2005年美國分子儀器公司正式進駐中國，總部設在上海。

Molecular Devices Corporation (MDC)公司成立于1983年，位于美國高科技密集的加里佛尼亞州，是一家致力于為生命科學和藥物研發(fā)工作者提供專業(yè)的、高精度、高通量、高性能的微孔板測讀分析儀和液體操作系統(tǒng)的廠商，擁有該領域的上百項專利技術，系列產品已被廣泛應用于藥物篩選、分子生物學、免疫學、細胞學、生物化學、電生理學等多個領域，是微孔板測讀分析領域的國際第一品牌。Universal Imaging Corporation和Axon Instruments現(xiàn)已成為MDC公司的成員。

MDC系列產品如下：
● 細胞成像 ImageXpress Micro，ImageXpress Ulltra，ImageXpress 5000A，MetaMorph
● 電生理系統(tǒng) IonWorks Quattro, PatchXpress 7000A, OpusXpress 6000A, 微電極放大器，數(shù)據(jù)獲取系統(tǒng)，電穿孔儀
● 熒光成像分析系統(tǒng) FLIPRTETRA?，F(xiàn)lexStation
● 液體處理系統(tǒng) 分液器，洗板機，細胞收獲器
● 生物芯片 Axon GenePix系列芯片掃描儀
● 酶標儀 光吸收SpectraMax系列，化學發(fā)光LMaxII384，熒光GeminiXPS/EM，多功能M2/M2e/M5/M5e，配套機械臂
● 試劑 GPCR分析，ADME分析，Microgenomics，激酶、磷酸酶、磷酸二酯酶分析，離子通道分析，轉錄因子分析，污染測試分析
● 軟件和認證 SoftMax Pro Validation Package和SpectraTest Hardware Validation Package(IQ/OQ/PQ認證)

Molecular Devices is now part of MDS Analytical Technologies, a division of MDS, Inc. Please see our Investor Relations pages for complete corporate information.

Background
Molecular Devices supplies high-performance bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. Its systems and consumables enable pharmaceutical and biotechnology companies to leverage advances in genomics and combinatorial chemistry by facilitating the high-throughput and cost-effective identification and evaluation of drug candidates. Molecular Devices' product solutions are based on its advanced core technologies that integrate its expertise in engineering, molecular and cell biology, electrophysiology, and chemistry. Molecular Devices enables its customers to improve their research productivity and effectiveness, which ultimately accelerates the complex process of discovering and developing new drugs. Molecular Devices has a record of developing innovative, first-to-market products that include instrumentation, software and reagent systems. Molecular Devices is based in Sunnyvale, California, and has offices in Union City, California, Downingtown, Pennsylvania, England, Germany, Korea, China and Japan.

History
Founded in 1983, Molecular Devices introduced its first microplate reader in 1987 and since then has continually broadened its solution set through a combination of internal R&D and acquisition. Molecular Devices acquired Universal Imaging Corporation in 2002 and Axon Instruments in 2004 broadening its portfolio to include electrophysiology products, scanners and analysis software for microarrays, and workstations for cell-based screening using high-resolution imaging. In March 2007, Molecular Devices was acquired by MDS, Inc. (Toronto, Canada). Molecular Devices and MDS division, MDS Sciex, have merged to become MDS Analytical Technologies.